Search

9 May 2022: KARPAS 25 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.

15 Mar 2022: The first in our new series of Impact Insight videos focuses on the exciting research commercialisation story behind Xampla.

19 Dec 2022: We have been licensing research tools for over a decade and can therefore fully support you through the process.

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Versed AI. Share:. Impact Insight video case study: Versed AI. The second in our Impact Insight video series focuses on Versed AI. It tells the story behind the creation

9 May 2022: KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.

18 Aug 2022: International research commercialisation collaboration TenU receives £4m funding boost

23 Mar 2022: The story behind the creation of iKVA, a University of Cambridge spin-out that uses AI to facilitate knowledge management for multinationals.

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Kalamna CIC. Share:. Impact Insight video case study: Kalamna toolkit. The third in our Impact Insight video series focuses on the licensing of the Kalamna toolkit for

9 May 2022: KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful in oncology research.

2 Feb 2022: University of Cambridge spin-out iKVA has secured £1.5m in seed funding to begin the rollout of its unique AI technology.

18 Jul 2022: Related news and case studies. Pause. Play. Review our answers to your most frequently asked questions.

15 Mar 2022: The second in our new series of Impact Insight videos focuses on the exciting research commercialisation story behind Versed AI.

15 Feb 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Watch our #nextgreatidea film. Share:. Our film is a distinctive take on innovation that showcases some of the world-changing ideas we have supported in the journey to market – from a

9 May 2022: KARPAS 707H Human myeloma cell line suitable for the generation of stable human hybridomas for the creation of fully human monoclonal antibodies.

4 Oct 2022: Six finalists announced for the 2022 Chris Abell Postdoc Business Plan Competition.

11 Apr 2022: This initiative links the Universities of Cambridge, Lincoln, Reading, Hertfordshire, and East Anglia to drive commercialisation of agri-tech research and innovation.

18 Aug 2022: More on Creative Cambridge. Discover Creative Cambridge. Learn more about our Creative Cambridge initiative, sign up to our dedicated newsletter to keep informed about forthcoming events and news for the creative

9 May 2022: KARPAS 1272 Human Myeloma cell line, useful in oncology research, developed at the University of Cambridge.

10 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. The journey of a University idea. How to make your commercial idea thrive. You have come up with an exciting commercial idea – but what do you do next? The diagram below gives an

17 Aug 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 28 July 2022. Semi-finalists announced in 2022 Chris Abell Postdoc Business Plan Competition. Share:. This year’s Chris Abell Postdoc Business Plan Competition is sponsored byand